APA (7th ed.) Citation

H, Z., C, W., & H, J. (2025). Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline. The Journal of dermatological treatment, 36(1), 2451811. https://doi.org/10.1080/09546634.2025.2451811

Chicago Style (17th ed.) Citation

H, Zhang, Wu C, and Jin H. "Successful Treatment of Etanercept- and Adalimumab-resistant Pyoderma Gangrenosum with Spesolimab, Moderate-dose Corticosteroids, and Minocycline." The Journal of Dermatological Treatment 36, no. 1 (2025): 2451811. https://doi.org/10.1080/09546634.2025.2451811.

MLA (9th ed.) Citation

H, Zhang, et al. "Successful Treatment of Etanercept- and Adalimumab-resistant Pyoderma Gangrenosum with Spesolimab, Moderate-dose Corticosteroids, and Minocycline." The Journal of Dermatological Treatment, vol. 36, no. 1, 2025, p. 2451811, https://doi.org/10.1080/09546634.2025.2451811.